Pliant Therapeutics Inc
F:9PT
Pliant Therapeutics Inc
F:9PT
Price:
0.9355
EUR
-3.31%
Market Closed
Market Cap:
€56m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
P
|
Pliant Therapeutics Inc
F:9PT
|
US |
|
Tenaris SA
F:TW10
|
LU |
|
R
|
Robert Half International Inc
F:RHJ
|
US |
|
E
|
Expeditors International of Washington Inc
SWB:EW1
|
US |
|
F
|
Federal National Mortgage Association
XMUN:FNM
|
US |
|
D
|
Dominion Energy Inc
XMUN:DOD
|
US |
|
Grindrod Ltd
OTC:GRDLY
|
ZA |
|
B
|
British American Tobacco plc
OTC:BTAFF
|
UK |
|
N
|
Nucor Corp
F:NUO
|
US |
|
Relmada Therapeutics Inc
NASDAQ:RLMD
|
US |
|
A
|
Alphabet Inc
F:ABEA
|
US |
|
G
|
Guangdong HEC Technology Holding Co Ltd
SSE:600673
|
CN |
|
H
|
Heineken NV
OTC:HINKF
|
NL |
|
G
|
Gold Fields Ltd
XMUN:EDGA
|
ZA |
|
E
|
Entergy Corp
DUS:ETY
|
US |
Multiples-Based Value
The Multiples-Based Value for 
Pliant Therapeutics Inc (9PT) under the Base Case is hidden
EUR.
Compared with the current market price of 0.9355 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
9PT Multiples-Based Value
LOCKED